Published by Josh White on 3rd March 2022
(Sharecast News) - Synairgen announced on Thursday that it was pausing clinical trial activities on its 'SNG001' compound in the treatment of Covid-19, at the behest of American authorities.
URL: http://www.digitallook.com/dl/news/story/32504777/...